Insider · CIK 0001746738

ALTMAN MICHAEL SETH

Reports to the SEC for 8 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001746738

Forms 4 and 5

Insider transactions

23 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-20	FRNMFreenome, Inc.C Conversion	Former Dir, Ofc, 10% Ownr	CConversion	+2.07M sh	—	—	2,352,500
2026-07-20	FRNMFreenome, Inc. · Class B Ordinary SharesC Conversion	Former Dir, Ofc, 10% Ownr	CConversion	−2.07M sh	—	—	0
2024-07-31	ARYA Sciences Acquisition Corp IVClass B ordinary sharesD Disposition to Issuer	Director, Chief Financial Officer, 10% Owner	DDisposition to Issuer	−2.65M sh	—	—	0
2024-07-31	ARYA Sciences Acquisition Corp IVClass B ordinary sharesD Disposition to Issuer	Director, Chief Financial Officer, 10% Owner	DDisposition to Issuer	−1M sh	—	—	2,647,500
2024-07-31	ARYA Sciences Acquisition Corp IVD Disposition to Issuer	Director, Chief Financial Officer, 10% Owner	DDisposition to Issuer	−499K sh	—	—	0
2024-06-14	NAUTNautilus Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45K sh	—	—	45,000
2024-06-13	FRNMFreenome, Inc.A Award	Former Dir, Ofc, 10% Ownr	AAward	+286K sh	$10.00	+$2.86M	286,250
2024-06-13	LYRALyra Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+30K sh	—	—	30,000
2023-06-30	LYRALyra Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2023-06-15	NAUTNautilus Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45K sh	—	—	45,000
2022-06-16	LYRALyra Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+7,250 sh	—	—	7,250
2022-06-15	NAUTNautilus Biotechnology, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+86.5K sh	—	—	86,467
2021-07-15	ARYA Sciences Acquisition Corp VA Award	Director, Chief Financial Officer, 10% Owner	AAward	+499K sh	$10.00	+$4.99M	499,000
2021-06-09	NAUTNautilus Biotechnology, Inc. · Class B ordinary sharesC Conversion	Director	CConversion	−3.65M sh	—	—	0
2021-06-09	NAUTNautilus Biotechnology, Inc.C Conversion	Director	CConversion	+3.65M sh	—	—	3,647,500
2021-06-09	NAUTNautilus Biotechnology, Inc.C Conversion	Director	CConversion	−499K sh	—	—	0
2021-06-09	NAUTNautilus Biotechnology, Inc.C Conversion	Director	CConversion	+499K sh	—	—	499,000
2021-06-09	NAUTNautilus Biotechnology, Inc. · Stock Option (Right to buy)A Award	Director	AAward	+44.4K sh	—	—	44,435
2021-05-26	LYRALyra Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+7,250 sh	—	—	7,250
2021-03-02	ARYA Sciences Acquisition Corp IVA Award	Director, Chief Financial Officer, 10% Owner	AAward	+499K sh	$10.00	+$4.99M	499,000
2020-08-11	NAUTNautilus Biotechnology, Inc.J Other	Director	JOther	+499K sh	$10.00	+$4.99M	499,000
2020-06-09	Cerevel Therapeutics Holdings, Inc.J Other	Director, Chief Financial Officer	JOther	+499K sh	$10.00	+$4.99M	499,000
2020-04-30	LYRALyra Therapeutics, Inc. · Stock OptionA Award	Director	AAward	+14.5K sh	—	—	14,500

Recent filings

Accepted (ET)
Jul 224
ALTMAN MICHAEL SETH0001746738-26-000003
SEC(opens sec.gov)
Jul 314
ALTMAN MICHAEL SETH0001140361-24-035164
SEC(opens sec.gov)
Jun 174
ALTMAN MICHAEL SETH0001062993-24-012727
SEC(opens sec.gov)
Jun 144
ALTMAN MICHAEL SETH0000950170-24-073651
SEC(opens sec.gov)
Jun 134
ALTMAN MICHAEL SETH0001140361-24-030023
SEC(opens sec.gov)
Jul 54
ALTMAN MICHAEL SETH0000950170-23-031867
SEC(opens sec.gov)
Jun 204
ALTMAN MICHAEL SETH0000899243-23-016073
SEC(opens sec.gov)
Jun 214
ALTMAN MICHAEL SETH0000899243-22-023342
SEC(opens sec.gov)
Jun 174
ALTMAN MICHAEL SETH0001062993-22-015188
SEC(opens sec.gov)
Jul 154
ALTMAN MICHAEL SETH0001140361-21-024476
SEC(opens sec.gov)
Jun 114
ALTMAN MICHAEL SETH0001140361-21-020674
SEC(opens sec.gov)
May 284
ALTMAN MICHAEL SETH0000899243-21-021191
SEC(opens sec.gov)
Mar 24
ALTMAN MICHAEL SETH0001140361-21-006908
SEC(opens sec.gov)

Companies

Address

C/O PERCEPTIVE CAPITAL SOLUTIONS HOLDING 51 ASTOR PLACE, 10TH FLOOR

NEW YORK, NY, 10003